| Smoldering Multiple Myeloma studied in …STUDIED_INderived85 of 85show fewer |
|---|
| → studied in | NCT05288062Phase 2 · terminated Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920084NA · active not recruiting A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06183489Phase 2 · active not recruiting Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114101Phase 3 · active not recruiting Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06987708NA · not yet recruiting Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03937635Phase 3 · recruiting Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05831358NA · active not recruiting Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169337Phase 3 · active not recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02603887early Phase 1 · active not recruiting Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05469893Phase 2 · recruiting Immuno-PRISM (PRecision Intervention Smoldering Myeloma) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644625recruiting CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140524Phase 2 · recruiting A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472778completed A Real-world Study in Participants With Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684274not yet recruiting Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839459Phase 2 · completed Denosumab for Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03301220Phase 3 · completed A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04776395Phase 2 · recruiting Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222286Phase 2 · completed Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731844Phase 2 · completed Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269592recruiting Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177527active not recruiting Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07446777NA · recruiting FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014646Phase 2 · active not recruiting Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214324recruiting Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726750recruiting Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640843NA · recruiting A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383143recruiting Promoting Diagnosis and Management of AL in Italy (ProDigALIty) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960555Phase 2 · active not recruiting Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR) · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136807recruiting Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955508Phase 2 · active not recruiting A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361694recruiting Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069751NA · recruiting A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236428Phase 2 · active not recruiting Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02886065Phase 1 · active not recruiting A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05767359Phase 2 · active not recruiting CAR- PRISM (PRecision Intervention Smoldering Myeloma) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06212323recruiting Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04850846Phase 2 · active not recruiting Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01237054Phase 2 · completed Imaging in MGUS, SMM and MM · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305662NA · not yet recruiting Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04370483early Phase 1 · active not recruiting Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03631043early Phase 1 · completed Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237803recruiting European Myeloma Network (EMN) Sample Project · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312255NA · recruiting Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055894NA · recruiting A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916771Phase 2 · completed Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06365060recruiting Screening for AL Amyloidosis in Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05841550Phase 1/Phase 2 · recruiting The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06762769Phase 2 · recruiting Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112827Phase 1/Phase 2 · completed Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895291recruiting Whole Body MRI in Oncology · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05597345Phase 2 · recruiting Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615572completed Screening to Improve Survival in AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04144387NA · active not recruiting Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289299Phase 2 · active not recruiting Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03673826Phase 2 · active not recruiting Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591614early Phase 1 · withdrawn Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903381Phase 2 · completed A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02279394Phase 2 · completed E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01838369Phase 2 · terminated A Phase II Study of BI-505 in Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415413Phase 2 · active not recruiting Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03850522Phase 2 · terminated PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05047107unknown Biology and Genetics of Smouldering Myeloma · condition mapped PROBABILISTIC · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727294unknown MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01079429terminated Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109407terminated Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01302886Phase 2 · completed Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02492750Phase 1 · completed Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784483Phase 1 · terminated Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01571726Phase 2 · withdrawn Imaging Studies and the Development of Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01248455Phase 2 · terminated A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952832Phase 2 · withdrawn Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03815279Phase 2 · enrolling by invitation A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441973Phase 2 · completed Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01884688Phase 2 · completed UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955395NA · completed Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099047Phase 2 · completed Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01718899Phase 1 · completed Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02240537Phase 1 · unknown Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503763Phase 2 · withdrawn Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919139completed S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02353572Phase 1/Phase 2 · terminated Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma · condition mapped ALIAS · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899353Phase 2 · terminated Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (49 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |